Delivery Order SPE2DB20D1109-SPE2DB25FP83J
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,593.95 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on a firm fixed price basis. The contract was competitively awarded without set-aside designation and is scheduled for completion by April 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $10,859.54 to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes (3 mL) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-competitive, firm fixed-price delivery order was placed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,177.85 to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,075.01 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes. This competitively awarded, firm fixed price contract was issued on August 21, 2025, with an ultimate completion date of August 22, 2025. The contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,068.33 firm fixed-price delivery order is for the supply of 4,568,037,376 units of the 60 mg/3 mL DUROLANE syringe. The contract has an ultimate completion date of April 28, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Durolane 60 mg/3 ml syringes at a ceiling value of $1,275.20. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the company's location...
- The U.S. Department of Defense has awarded a $29,615.72 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with an ultimate completion date of October 7, 2024, is for the supply of DUROLANE 60MG/3ML 1S medical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the Defense Logistics Agency (DLA) Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,275.20 firm fixed-price delivery order for Durolane 60 mg/3 ml syringes on June 5, 2025, with an ultimate completion date of June 6, 2025. This non-competitive, non-set-aside award is being performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $10,889.59 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Durolane 60 mg/3 mL syringes. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a $18,044.80 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Durolane 60 mg/3 ml syringes. This firm fixed-price contract, with a completion date of September 11, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the vendor's location in Conshohocken, Pennsylvania, where the company...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP83JDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,506.50 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes on a firm fixed price basis. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive portfolio of medications and medical supplies to support military and veteran healthcare systems. The company's federal contract awards demonstrate consistent capability in delivering diverse pharmaceutical products ranging from specialty medications to generic drugs, vaccines, and medical devices. Under the DLA's Pharmaceutical Prime Vendor Global Program structure, AmerisourceBergen Drug Corp serves multiple government healthcare systems including the Defense Health Agency and U.S. Coast Guard through its flexible contract vehicle, positioning the company as a key supplier for federal medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.5k | 9/25/25 |